FLGT Relative Valuation - Fulgent Genetics Inc

Watchlist Manager

Watchlist

Price: 16.37 USD -1.8% Market Closed

Market Cap: $511.2m

	Fulgent Genetics Inc NASDAQ:FLGT	US
	Telefonica Brasil SA BOVESPA:VIVT3	BR
	Epiroc AB STO:EPI A	SE
	ConvaTec Group PLC LSE:CTEC	UK
C	Cosmos Exploration Ltd ASX:C1X	AU

Multiples-Based Value

The Multiples-Based Value of one FLGT stock under the Base Case scenario is hidden USD. Compared to the current market price of 16.37 USD, Fulgent Genetics Inc is hidden .

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Multiples-Based Value calculated?

FLGT Multiples-Based Value

Unlock

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
US		Fulgent Genetics Inc NASDAQ:FLGT	508.8m USD	1.6	-8.4	-2.6	-1.9
US		CVS Health Corp NYSE:CVS	90.5B USD	0.2	51.2	13.4	13.4
US	C	Cigna Group XMUN:CGN	67B EUR	0.3	13.3	7.8	9.9
US		Cigna Corp NYSE:CI	71.7B USD	0.3	12	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	25.1B EUR	1.1	19.6	9.3	13.9
DE		Fresenius Medical Care AG XMUN:FME	22.3B EUR	1.1	23	8.9	16.5
US		Laboratory Corporation of America Holdings NYSE:LH	22.1B USD	1.6	25.1	12.1	17.5
US		Quest Diagnostics Inc NYSE:DGX	21.8B USD	2	22.1	12	16.1
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.7B EUR	0.6	11.2	5.4	9.9
US		Guardant Health Inc NASDAQ:GH	11.5B USD	11.7	-27.6	-30.2	-27.5
US		DaVita Inc NYSE:DVA	10.7B USD	0.8	14.4	7.3	9.9

				Revenue Growth	P/S to Growth
US		Fulgent Genetics Inc NASDAQ:FLGT	Average P/S: 1.9 1.6	11%	0.1
US		CVS Health Corp NYSE:CVS	0.2	4%	0.1
US	C	Cigna Group XMUN:CGN	0.3	6%	0
US		Cigna Corp NYSE:CI	0.3	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.1	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.1	3%	0.4
US		Laboratory Corporation of America Holdings NYSE:LH	1.6	6%	0.3
US		Quest Diagnostics Inc NYSE:DGX	2	5%	0.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.6	3%	0.2
US		Guardant Health Inc NASDAQ:GH	11.7	29%	0.4
US		DaVita Inc NYSE:DVA	0.8	4%	0.2

				Earnings Growth	PEG
US		Fulgent Genetics Inc NASDAQ:FLGT	Average P/E: 21.3 Negative Multiple: -8.4	N/A	N/A
US		CVS Health Corp NYSE:CVS	51.2	90%	0.6
US	C	Cigna Group XMUN:CGN	13.3	19%	0.7
US		Cigna Corp NYSE:CI	12	19%	0.6
DE		Fresenius SE & Co KGaA XETRA:FRE	19.6	26%	0.8
DE		Fresenius Medical Care AG XMUN:FME	23	16%	1.4
US		Laboratory Corporation of America Holdings NYSE:LH	25.1	27%	0.9
US		Quest Diagnostics Inc NYSE:DGX	22.1	12%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.2	16%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -27.6	N/A	N/A
US		DaVita Inc NYSE:DVA	14.4	20%	0.7

				EBITDA Growth	EV/EBITDA to Growth
US		Fulgent Genetics Inc NASDAQ:FLGT	Average EV/EBITDA: 9.5 Negative Multiple: -2.6	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.4	28%	0.5
US	C	Cigna Group XMUN:CGN	7.8	4%	1.9
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	9.3	10%	0.9
DE		Fresenius Medical Care AG XMUN:FME	8.9	7%	1.3
US		Laboratory Corporation of America Holdings NYSE:LH	12.1	10%	1.2
US		Quest Diagnostics Inc NYSE:DGX	12	6%	2
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	5.4	7%	0.8
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -30.2	N/A	N/A
US		DaVita Inc NYSE:DVA	7.3	4%	1.8

				EBIT Growth	EV/EBIT to Growth
US		Fulgent Genetics Inc NASDAQ:FLGT	Average EV/EBIT: 13.4 Negative Multiple: -1.9	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.4	22%	0.6
US	C	Cigna Group XMUN:CGN	9.9	5%	2
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	13.9	12%	1.2
DE		Fresenius Medical Care AG XMUN:FME	16.5	11%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	17.5	18%	1
US		Quest Diagnostics Inc NYSE:DGX	16.1	9%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	9.9	11%	0.9
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -27.5	N/A	N/A
US		DaVita Inc NYSE:DVA	9.9	5%	2

Fulgent Genetics Inc
NASDAQ:FLGT

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

FLGT Competitors Multiples
Fulgent Genetics Inc Competitors

See Also

Company

Help

Tools

Stocks

Fulgent Genetics Inc NASDAQ:FLGT

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

FLGT Competitors Multiples Fulgent Genetics Inc Competitors

See Also

Company

Help

Tools

Stocks

Fulgent Genetics Inc
NASDAQ:FLGT

FLGT Competitors Multiples
Fulgent Genetics Inc Competitors